How Fasting Rewrites Your Epigenome to Slow Aging

Fasting has long been recognized for its metabolic benefits, but emerging science reveals it operates at a far deeper level — reshaping the very epigenomic landscape that governs how cells age. This review, co-authored by Valter Longo of USC's Longevity Institute, synthesizes the latest mechanistic evidence on how fasting modulates gene regulation to promote healthspan.

At the core of fasting's anti-aging effects are evolutionarily conserved nutrient-sensing pathways, particularly AMPK and the sirtuin family of proteins. When nutrients are scarce, these sensors activate and directly influence chromatin accessibility — essentially determining which regions of DNA are readable. This leads to coordinated changes in histone modifications, DNA methylation, and non-coding RNA expression, producing transcriptional programs optimized for cellular survival and repair.

Key outcomes of this epigenomic remodeling include enhanced autophagy (the cellular self-cleaning process), improved stem cell function, and a dampening of chronic low-grade inflammation — a hallmark driver of aging often called inflammaging. Crucially, fasting appears to counteract epigenetic drift, the progressive loss of precise gene regulation that accumulates with age and underlies tissue dysfunction.

These mechanisms connect fasting to resistance against several major age-related conditions. The review highlights metabolic disorders, neurodegeneration, and cancer as disease categories where fasting-induced epigenomic changes may offer meaningful protection. Cell-type-specific effects are also noted, suggesting fasting's benefits are not uniform but tailored to the demands of different tissues.

The authors acknowledge important caveats. Much of the mechanistic evidence derives from animal models and cell studies, and translating optimal fasting protocols to diverse human populations remains a challenge. Nonetheless, the translational opportunities are significant, and fasting-inspired interventions — including dietary restriction, fasting-mimicking diets, and pharmacological mimetics of fasting pathways — represent a compelling frontier for healthspan medicine.